You are here

Companies

CataloniaBioHT
14.12.2017

The call for elections to choose the board of directors will open on 9 January

 

 

Presentació estudi CataloniaBio i EY
11.10.2017

Most of the funding comes from inside Catalonia, through venture capital funds, licensing deals and business angels and family offices, according to study from CataloniaBio and EY

Banner de l'ASEBIO Investor Day 2017
27.06.2017

The deadline to sign up for ASEBIO Investor Day is 30 June

Josep Castells Inkemia
16.05.2017

InKemia, which now has a network of 14 companies in the healthcare sector, is creating a new fund for start-ups and spin-offs

Marc Martinell
07.03.2017

The drug, called MIN-102 and used to treat adrenoleukodystrophy, has also recently been granted this designation from the European Medicines Agency

Joan Bertran
23.02.2017

Thanks to the participation of social impact investors, the company can continue to focus their therapies on pediatrics

Parc Tecnològic Vallès
22.02.2017

The product, Zelium, is a therapeutic alternative for treating a serious complication in diabetic patients

SOM Biotech
20.01.2017

The company will use this capital to grow in the United States and fund a clinical trial on its repositioned drug to treat Huntington disease 

Transplant Biomedicals
23.01.2017

Caixa Capital Risc and Kereon Partners have invested in this spin-off created through technology transfer from IDIBAPS-Hospital Clínic de Barcelona

Bionure Estamosaesto
17.01.2017

The biotech firm has opened a crowdequity round of funding on the Capital Cell platform and has created a campaign on social media